What’s it take to raise $700M-plus for a biotech startup? Steve Harr has some thoughts on that
When Sana Biotechnology’s’ crew emerged from stealth mode to officially launch the company, no one said exactly how much money they had raised. With Bob Nelsen at ARCH and Noubar Afeyan at Flagship involved, and a leadership team topped by Steve Harr and Hans Bishop from the Juno founders club, you knew it was some kind of unicorn-style deal.
Now, they’ve come out with the number. And it’s a big one.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.